Glenmark Pharma is likely to report 16 percent year-on-year growth in fourth quarter revenue at Rs 1,240 crore, whilenet profit is seen flat at Rs 150 crore, according to a CNBC-TV18 poll.
first published: May 7, 2013 01:47 pm
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

